OA09698A - Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens - Google Patents

Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens

Info

Publication number
OA09698A
OA09698A OA60209A OA60209A OA09698A OA 09698 A OA09698 A OA 09698A OA 60209 A OA60209 A OA 60209A OA 60209 A OA60209 A OA 60209A OA 09698 A OA09698 A OA 09698A
Authority
OA
OAPI
Prior art keywords
immunogens
particles used
antiviral agents
retroviral particles
replicating recombinant
Prior art date
Application number
OA60209A
Other languages
English (en)
Inventor
Omar K Haffar
Shiu-Lok Hu
Allen W Senear
Bruce M Travis
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of OA09698A publication Critical patent/OA09698A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA60209A 1989-11-20 1992-05-19 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens OA09698A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20

Publications (1)

Publication Number Publication Date
OA09698A true OA09698A (en) 1993-08-30

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60209A OA09698A (en) 1989-11-20 1992-05-19 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens

Country Status (14)

Country Link
EP (1) EP0502105A4 (hu)
JP (1) JPH05503629A (hu)
KR (1) KR920703639A (hu)
AU (1) AU636944B2 (hu)
CA (1) CA2068713A1 (hu)
ES (1) ES2052478T1 (hu)
FI (1) FI922277A0 (hu)
GR (1) GR930300005T1 (hu)
HU (1) HUT60506A (hu)
NO (1) NO921969L (hu)
OA (1) OA09698A (hu)
TW (1) TW216446B (hu)
WO (1) WO1991007425A1 (hu)
ZA (1) ZA909302B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033175C (en) * 1989-06-01 2005-01-11 Gail P. Mazzara Self-assembled, defective, non-self-propagating viral particles
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
JP2852395B2 (ja) * 1991-11-08 1999-02-03 ファルマシア・アンド・アップジョン・カンパニー ネコ白血病ウイルスワクチン
JPH07505412A (ja) * 1992-04-14 1995-06-15 ブリティッシュ バイオテック ファーマシューティカルズリミテッド Ctl応答の誘導
EP1473369B1 (en) 1993-01-26 2009-01-07 The Trustees of the University of Pennsylvania (a corporation of Pennsylvania) Compositions and methods for delivery of genetic material
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
ES2249760T3 (es) 1993-01-26 2006-04-01 The Trustees Of The University Of Pennsylvania (A Corporation Of Pennsylvania) Composiciones y procedimientos de administracion de materias geneticas.
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
WO1996030523A2 (en) * 1995-03-31 1996-10-03 Hans Wolf Antigen presentation system based on retrovirus-like particles
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性hivc型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
WO2002072754A2 (en) 2001-03-08 2002-09-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mva expressing modified hiv envelope, gag, and pol genes
EP1418940A4 (en) 2000-03-02 2006-09-20 Univ Emory DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
CA2634992C (en) 2001-07-05 2012-10-16 Novartis Vaccines And Diagnostics, Inc. Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US9839684B2 (en) 2011-04-06 2017-12-12 Biovaxim Limited Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
WO2018170270A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Varicella zoster virus (vzv) vaccine
WO2018170256A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Herpes simplex virus vaccine
MA55321A (fr) * 2019-03-15 2022-01-19 Modernatx Inc Vaccins à base d'arn contre le vih

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトt細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥hivプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
JPH05501201A (ja) * 1989-10-16 1993-03-11 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 非感染性hiv―1粒子およびそれらの使用

Also Published As

Publication number Publication date
JPH05503629A (ja) 1993-06-17
GR930300005T1 (hu) 1993-04-28
WO1991007425A1 (en) 1991-05-30
FI922277A (fi) 1992-05-19
CA2068713A1 (en) 1991-05-21
KR920703639A (ko) 1992-12-18
AU636944B2 (en) 1993-05-13
NO921969L (no) 1992-06-26
HUT60506A (en) 1992-09-28
EP0502105A1 (en) 1992-09-09
HU9201659D0 (en) 1992-08-28
FI922277A0 (fi) 1992-05-19
EP0502105A4 (en) 1993-02-24
TW216446B (hu) 1993-11-21
NO921969D0 (no) 1992-05-19
AU6905591A (en) 1991-06-13
ZA909302B (en) 1991-09-25
ES2052478T1 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
EP0502105A4 (en) Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
ZA875671B (en) Titanocenes and their use
PH21379A (en) N-phenylsulfonyl-n'-pyrimidinyl and triazinyl-ureas
PH25866A (en) Sulfonylurea compounds and their herbicides
EP0256981A3 (en) Titanocenes and their use
ZA846525B (en) (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
EP0137242A3 (en) (substituted) phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
PH27609A (en) Antiviral agents
GB8610531D0 (en) Herbicides
GB8610530D0 (en) Herbicides
IL82798A0 (en) Substituted 3-amino-2-benzoyl-cyclohex-2-enones and their use as herbicides
EP0406416A4 (en) Anti-hiv agent
EP0450065A4 (en) Antiviral agent
GB2184944B (en) Antiviral agents
GB8911158D0 (en) Antiviral pyridazinamines
EP0243192A3 (en) Antiviral 8-phenylxanthines
GB2230751B (en) Aerospace structures
PH27414A (en) 1,2,4-oxadiazolyl-phenoxy-alkylisoxazoles and their use as antiviral agents
EP0440710A4 (en) New antiviral agents
GB2190824B (en) Pendant
GB8612062D0 (en) Herbicides
GB8610532D0 (en) Herbicides
GB8612616D0 (en) Alpha-alumina particles
GB8617949D0 (en) Phenoxybenzisoxazole herbicides
GB8617948D0 (en) Phenoxybenzisoxazole herbicides